Upon investigation of the patient sample, an interference against a component of the reagent was confirmed.This interference is covered in product labeling: in extremely rare cases (global incidence: < 1 in 10 million), patients may show discrepant results when tested with the assay kit (values < limit of detection) due to a nt-probnp genetic variant.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings.
|